PloS one

Molecules (Basel, Switzerland)

acs nano

methods in molecular biology (clifton, nj)

Cells

Multiple sclerosis and related disorders

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

revista espanola de quimioterapia : publicacion oficial de la sociedad espanola de quimioterapia

expert opinion on biological therapy

journal of the american society for mass spectrometry

Complex & intelligent systems

[1] Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase.

[2] Research applications of primary biodiversity databases in the digital age.

[3] Critical Comparison of the Superoxide Dismutase-Like Activity of Carbon Anti-Oxidant Nanozymes by Direct Superoxide Consumption Kinetic Measurements.

[4] Quality Control of Immunophenotyping.

[5] A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.

[6] Mass Spectrometry Characterization of Higher Order Structural Changes Associated with the Fc-glycan Structure of the NISTmAb Reference Material, RM 8761.

[7] CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents.

[8] The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

[9] Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

[10] antibody–drug conjugates for cancer therapy

[11] immunotherapy of cancer: towards a new era

[12] schistosoma mansoni: description of a potentially useful monoclonal antibody that recognizes soluble egg antigen (sea)

[13] natural killer cell based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity

[14] antibody aggregation: insights from sequence and structure

[15] anti-interleukin 5 (il-5) and il-5ra biological drugs: efficacy, safety, and future perspectives in severe eosinophilic asthma

[16] severe asthma: anti-ige or anti-il-5?

[17] new monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma

[18] differential sensitivity of regulatory and effector t cells to cell death: a prerequisite for transplant tolerance

[19] protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles

[20] targeted therapy in gastrointestinal malignancies

[21] Comprehensive Leaf Cell Wall Analysis Using Carbohydrate Microarrays Reveals Polysaccharide-Level Variation between Vitis Species with Differing Resistance to Downy Mildew

[22] Systematic review of MCDM approach applied to the medical case studies of COVID-19: trends, bibliographic analysis, challenges, motivations, recommendations, and future directions.

[23] Erratum: Identification of a novel variant form of aspergillus fumigatus CalC and generation of Anti-CalC monoclonal antibodies (Medical Mycology Journal, (2019), 60, 1, (11-16), 10.3314/mmj.18-00013)

[24] Case Reports of DRESS Syndrome and Symptoms Consistent with DRESS Syndrome Following Treatment with Recently Marketed Monoclonal Antibodies

[25] Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review.

[26] Physicochemical stability of monoclonal antibodies: a review.

[27] Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies

[28] Integration of Aqueous Two-Phase Extraction as Cell Harvest and Capture Operation in the Manufacturing Process of Monoclonal Antibodies.

[29] Development and validation of monoclonal antibodies against N6-methyladenosine for the detection of RNA modifications.

[30] Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration.

[31] Generation of Monoclonal Antibodies against Ag85A Antigen of Mycobacterium tuberculosis and Application in a Competitive ELISA for Serodiagnosis of Bovine Tuberculosis

[32] A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.

[33] Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.

[34] Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

[35] Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling.

[36] Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.

[37] Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies

[38] Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

[39] Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein

[40] Serology of Mycobacteria: Characterization of Antigens Recognized by Monoclonal Antibodies

[41] Preparation and Application of Yellow Fever Virus NS1 protein-specific Monoclonal Antibodies

[42] p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies

[43] adverse events of monoclonal antibodies used for cancer therapy

[44] in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections

[45] monoclonal antibodies as immune modulators for cancer therapy

[46] study of t-cell subsets, b and nk cells in iranian patients with behcet's disease by monoclonal antibodies

[47] inhibition of p-selectin and psgl-1 using humanized monoclonal antibodies increases the sensitivity of multiple myeloma cells to bortezomib

[48] production of monoclonal antibodies against streptococcus mutans antigens produção de anticorpos monoclonais contra antígenos de streptococcus mutans

[49] application of monoclonal antibodies against bioactive natural products: eastern blotting and preparation of knockout extract

[50] preparation and partial characterization of monoclonal antibodies specific for the nascent non-triple helical form of the type iv collagen alpha 1 chain

[51] a quantitative method for detecting ara h 2 by generation and utilization of monoclonal antibodies

[52] new monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma

[53] development of monoclonal antibodies in china: overview and prospects

[54] kir genes and their ligands predict the response to anti-2 egfr monoclonal antibodies in solid tumors

[55] Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice

[56] Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies

[57] Ultrastructural localization of epitopes recognized by monoclonal antibodies produced to rat Pneumocystis carinii

[58] Topography of apolipoprotein B in subcellular fractions of rabbit liver probed with a panel of monoclonal antibodies

[59] Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

[60] The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

[61] A comparative study of polyclonal and monoclonal antibodies for immunocytochemical localization of cytosolic aspartate aminotransferase in rat liver

[62] Monoclonal Antibodies as Potential Treatment Drugs for Nsp15 and 3CL^pro Proteins

[63] Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast

[64] Longitudinal head-to-head comparison of ¹¹C-PiB and ¹⁸F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease